October102025 Trading Strategies Exponential Debt Growth Under Yield Curve Control: Is the Era of Free Markets Ending? Yield curve control is when central banks try to control interest rates (the cost of money) and the cost of borrowing. They pick a certain interest rate
October102025 Trading Strategies Demystifying Short Selling: How to Profit in a Bear Market Short selling is betting on the decline of a stock price. You borrow shares from your broker that you don't own and sell them at the current market
October102025 IPOs & Earnings FG Nexus Accelerates ETH Holdings to 49,715 (About $229 Million) as It Aims to Be the World’s Largest Corporate Holder of ETH Read Press Release for FG Nexus (FGNX) published on Sep. 19, 2025 - FG NEXUS ACCELERATES TOTAL ETH HOLDINGS TO 49,715
October102025 IPOs & Earnings Telesat completes 62% equity distribution of Telesat Lightspeed to its indirect subsidiary of Telesat Corporation; operations unchanged Read Press Release for Telesat - Class A Common Shares And Class B Variable Voting Shares (TSAT) published on Sep. 12, 2025 - Telesat announces equity
October102025 IPOs & Earnings Motorcar Parts of America to Report Fiscal 2026 First Quarter Results, Host Investor Conference Call on Aug. 11 at 10:00 a.m. PT Read Press Release for Motorcar Parts Of America (MPAA) published on Aug. 4, 2025 - Motorcar Parts of America to Report Fiscal 2026 First Quarter
October102025 IPOs & Earnings BitMine Immersion Debuts ‘Alchemy of 5%’ Investor Presentation and Launches ‘Chairman’s Message’ Monthly Video Series Hosted by Tom Lee Read Press Release for Bitmine Immersion Techs (BMNR) published on Jul. 28, 2025 - BitMine Immersion (BMNR) Announces Release of Investor Presentation
October102025 IPOs & Earnings Get More from Portfolio Reports: A Step-by-Step Guide to Adding Portfolio History Stock Rover’s Portfolio History feature empowers investors to track how the value and composition of their portfolios evolve over time. Built as a
October102025 Listed Companies Ergomed Agrees to £703m Cash Bid From Permira for Private-Equity Takeover The potential deal is the latest in a string of private equity buyouts in the pharmaceutical and biotech sector, including Instem, Dechra and Abcam
October102025 Listed Companies Is Phoenix Group’s Private-Equity Bet Doomed by an FCA Probe and IFRS 17 Changes? An indifferent set of results and an unfortunate PE stake puts Phoenix insurance under pressure
October102025 Listed Companies Mattioli Woods posts strong inflows as recurring revenue grows 4% organically and discretionary assets under management rise to £4.6bn Regulatory wobbles hit the share price over the winter but the asset manager continues its consistent performance